ProShares UltraShort Valuation
| RXD Etf | USD 8.83 0.15 1.67% |
At this time, the etf appears to be overvalued. ProShares UltraShort holds a recent Real Value of $8.19 per share. The prevailing price of the etf is $8.83. Our model determines the value of ProShares UltraShort from analyzing the etf fundamentals such as Number Of Employees of 10, net asset of 9.15 M, and One Year Return of (16.10) % as well as examining its technical indicators and probability of bankruptcy.
Overvalued
Today
Please note that ProShares UltraShort's price fluctuation is not too volatile at this time. Calculation of the real value of ProShares UltraShort is based on 3 months time horizon. Increasing ProShares UltraShort's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the ProShares etf is determined by what a typical buyer is willing to pay for full or partial control of ProShares UltraShort Health. Since ProShares UltraShort is currently traded on the exchange, buyers and sellers on that exchange determine the market value of ProShares Etf. However, ProShares UltraShort's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 8.83 | Real 8.19 | Hype 8.82 |
The real value of ProShares Etf, also known as its intrinsic value, is the underlying worth of ProShares UltraShort ETF, which is reflected in its stock price. It is based on ProShares UltraShort's financial performance, growth prospects, management team, or industry conditions. The intrinsic value of ProShares UltraShort's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
Estimating the potential upside or downside of ProShares UltraShort Health helps investors to forecast how ProShares etf's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of ProShares UltraShort more accurately as focusing exclusively on ProShares UltraShort's fundamentals will not take into account other important factors: Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates ProShares UltraShort's worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in ProShares UltraShort and how it compares across the competition.
About ProShares UltraShort Valuation
The etf valuation mechanism determines ProShares UltraShort's current worth on a weekly basis. Our valuation model uses a comparative analysis of ProShares UltraShort. We calculate exposure to ProShares UltraShort's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of ProShares UltraShort's related companies.The fund invests in financial instruments that ProShare Advisors believes, in combination, should produce daily returns consistent with the funds investment objective. Ultrashort Health is traded on NYSEARCA Exchange in the United States.
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in ProShares UltraShort Health. Also, note that the market value of any etf could be closely tied with the direction of predictive economic indicators such as signals in housing. You can also try the Competition Analyzer module to analyze and compare many basic indicators for a group of related or unrelated entities.
The market value of ProShares UltraShort is measured differently than its book value, which is the value of ProShares that is recorded on the company's balance sheet. Investors also form their own opinion of ProShares UltraShort's value that differs from its market value or its book value, called intrinsic value, which is ProShares UltraShort's true underlying value. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. Because ProShares UltraShort's market value can be influenced by many factors that don't directly affect ProShares UltraShort's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
It's important to distinguish between ProShares UltraShort's intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding ProShares UltraShort should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. Meanwhile, ProShares UltraShort's quoted price indicates the marketplace figure where supply meets demand through bilateral consent.